{'fraction_non_alphanumeric': 0.02788339670468948, 'fraction_numerical': 0.0076045627376425855, 'mean_word_length': 4.93984962406015, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 1, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Chemotherapy of advanced and recurrent colorectal cancer].

Colorectal cancer is one of the most resistant tumors to chemotherapy. The efficacy of many kinds of anti-tumor drugs to the patients with colorectal cancer had been investigated, however most of the drugs was not effective or showed low response rates. As a few effective anti-tumor drug, 5-FU and its derivatives, nitrosoureas and mitomycin C were indicated. Response rates of combinations of these drugs were 20-30%. Methotrexate-5-FU with leucovorin therapy at proper administration intervals showed relatively high response rate to the patients. Effects of intra-arterial infusion of the drugs which often performed to the liver metastases were not so well as expected. Developments of new anti-tumor agents were essential.